amatuximab

amatuximab
Trade Name
Orphan Indication Malignant pleural mesothelioma
USA Market Approval USA
USA Designation Date 2012-09-28 00:00:00
Sponsor Morphotek, Inc.;210 Welsh Pool Road;Exton, Pennsylvania, 19341